EP2751117 - METALLOENZYME INHIBITOR COMPOUNDS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.08.2017 Database last updated on 28.06.2024 | |
Former | Examination is in progress Status updated on 25.01.2017 | Most recent event Tooltip | 25.08.2017 | Application deemed to be withdrawn | published on 27.09.2017 [2017/39] | Applicant(s) | For all designated states Innocrin Pharmaceuticals, Inc. 2250 Perimeter Park Drive, Suite 320 Morrisville, NC 27560 / US | [2015/09] |
Former [2014/28] | For all designated states Viamet Pharmaceuticals, Inc. 2250 Perimeter Park Drive Suite 320 Morrisville, NC 27560 / US | Inventor(s) | 01 /
HOEKSTRA, William, J. 7 Treviso Place Durham, NC 27707 / US | 02 /
SCHOTZINGER, Robert, J. 7000 Potomac Court Raleigh, NC 27613 / US | [2014/28] | Representative(s) | Adam, Holger Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | [N/P] |
Former [2014/28] | Adam, Holger Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15 80539 München / DE | Application number, filing date | 12828782.8 | 27.08.2012 | WO2012US52483 | Priority number, date | US201161528953P | 30.08.2011 Original published format: US 201161528953 P | [2014/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2013033004 | Date: | 07.03.2013 | Language: | EN | [2013/10] | Type: | A2 Application without search report | No.: | EP2751117 | Date: | 09.07.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.03.2013 takes the place of the publication of the European patent application. | [2014/28] | Search report(s) | International search report - published on: | KR | 25.04.2013 | (Supplementary) European search report - dispatched on: | EP | 27.05.2015 | Classification | IPC: | C07D513/04, C07D417/12, A61K31/542, A61K31/427, A61P31/18 | [2014/28] | CPC: |
C07D277/24 (EP,US);
A01N43/78 (US);
A01N43/84 (US);
A01N43/90 (US);
A61K31/427 (EP,US);
A61K31/542 (EP,US);
A61K45/06 (EP,US);
A61P1/04 (EP);
A61P13/08 (EP);
A61P15/00 (EP);
A61P15/14 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P17/14 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P31/04 (EP);
A61P31/10 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P5/24 (EP);
A61P9/00 (EP);
C07D277/22 (EP,US);
C07D277/28 (EP,US);
C07D277/32 (EP,US);
C07D277/56 (EP,US);
C07D417/06 (EP,US);
| C-Set: |
A61K31/427, A61K2300/00 (EP);
A61K31/542, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/28] | Title | German: | METALLOENZYMHEMMERVERBINDUNGEN | [2014/28] | English: | METALLOENZYME INHIBITOR COMPOUNDS | [2014/28] | French: | COMPOSÉS INHIBITEURS DE MÉTALLOENZYME | [2014/28] | Entry into regional phase | 24.03.2014 | National basic fee paid | 24.03.2014 | Search fee paid | 24.03.2014 | Designation fee(s) paid | 24.03.2014 | Examination fee paid | Examination procedure | 24.03.2014 | Examination requested [2014/28] | 16.12.2015 | Amendment by applicant (claims and/or description) | 23.09.2016 | Despatch of a communication from the examining division (Time limit: M06) | 04.04.2017 | Application deemed to be withdrawn, date of legal effect [2017/39] | 15.05.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/39] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.09.2016 | Fees paid | Renewal fee | 27.08.2014 | Renewal fee patent year 03 | 27.08.2015 | Renewal fee patent year 04 | 29.08.2016 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9954309 (TAKEDA CHEMICAL INDUSTRIES LTD [JP], et al) [X] 1-4,6-8,11,14,15,18,19 * example 65 * * page 116, line 8 - page 117, line 2 * * page 30, line 28 - page 32, line 34 *; | [Y]JPH08151341 (SAGAMI CHEM RES) [Y] 1-15,18,19 * the whole document *; | [Y]WO9501968 (ASTRA AB [SE], et al) [Y] 1-15,18,19 * example 4 * * claims 1,10 * | International search | [X]WO9954309 (TAKEDA CHEMICAL INDUSTRIES LTD [JP], et al); | [A]US2011015158 (SCHOTZINGER ROBERT J [US], et al); | [A]JP2003079394 (WARNER LAMBERT CO); | [A]WO2011082245 (VIAMET PHARMACEUTICALS INC, et al) |